Caption Management’s Wave Life Sciences WVE Stock Holding History

Caption Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	160,000 +140,800	+733%	+$1.83M	0.01%	979
2025 Q4	$326K	Buy	+19,200	New	+$195K	﹤0.01%	1316
2025 Q2	–	Sell	-25,000	Closed	-$202K	–	1961
2025 Q1	$202K	Sell	25,000 -100,000	-80%	-$1.09M	﹤0.01%	1269
2024 Q4	$1.55M	Buy	+125,000	New	+$1.67M	0.01%	787
2021 Q2	–	Sell	-126,600	Closed	-$711K	–	1612
2021 Q1	$711K	Buy	+126,600	New	+$1.22M	0.02%	741
2020 Q1	–	Sell	-36,000	Closed	-$289K	–	1113
2019 Q4	$289K	Buy	36,000 +16,000	+80%	+$392K	0.01%	692
2019 Q3	$411K	Hold	20,000	–	–	0.02%	512
2019 Q2	$522K	Buy	+20,000	New	+$561K	0.03%	471

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Caption Management's WVE Position: Q1 2026 in Review

Caption Management opened a new position in Wave Life Sciences (WVE) in Q1 2026: 43,200 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings. This is a return to the name: Caption Management previously reported a position in WVE as recently as Q3 2025.

Caption Management first reported a position in WVE in Q2 2019 and has held it in 8 quarters since. The position peaked at $2.1M in Q2 2019. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Caption Management held 43,200 shares of Wave Life Sciences worth $313K as of Q1 2026.
Wave Life Sciences was a new Caption Management position in Q1 2026.
Wave Life Sciences made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1293 holding.
Caption Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 8 quarters since.
Caption Management's Wave Life Sciences position peaked at $2.1M in Q2 2019.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.